Citations

Showing 10 of 108162 citations.

Augmentation Phalloplasty for Acquired Penile Shortening: A Systematic Review of Techniques, Outcomes, Patient Satisfaction, and Limitations
Banuelos, Joseph, Davis, Matthew J. , Kreutz‐Rodrigues, Lucas , Vyas, Krishna S. , Abu‐Ghname, Amjed , Morrison, Shane D.

Mayo Clinic

The Journal of Sexual Medicine | December 10, 2019 | Volume: 17 | Issue: 2 | Pages: 331-341

10.1016/j.jsxm.2019.11.260 | PMID 31831387 Get It

AbstractIntroductionAlthough an infrequent cause of small penile size in adult men, acquired penile shortening represents a particular reconstructive challenge due to preexisting penile anatomic deformities.AimWith numerous techniques being performed, the purpose of our study is to assess available literature on length enhancement procedures used for acquired penile shortening deformities.MethodsA systematic review was performed using the guidelines outlined in the Preferred Reporting Items for Systematic reviews and Meta-analyses. Medline/PubMed, Scopus, and Cochrane Databases were used to identify papers on augmentation Phalloplasty in non-transgender males with acquired penile shortening from 1990 to 2018.Main Outcome MeasureOutcomes, complications, and patient-reported satisfaction were analyzed.Results12 articles, involving 931 patients and 8 primary procedures, met our inclusion criteria. The majority of articles had level of evidence of 4 (83%) and Newcastle Ottawa Scale score of 6 (92%, moderate risk of bias). All studies reported mean penile length gain; however, inconsistent methodology was used when measuring penile dimensions. Mean length gain ranged from 0.6 to 6.4 cm. Overall, the mean complication rate for all techniques ranged from 0% to 50%. Post-operative satisfaction was reported in 10 (83%) studies, 7 of which used a validated scale. Patients were generally satisfied, with reported satisfaction rates ranging from 77% to 100%.Clinical ImplicationsWhile numerous procedures have been described, the significant limitations in the available data preclude identifying a single superior procedure.Strengths & LimitationsThe significant heterogeneity in the reported literature is a limitation of this study and highlights the need for standardized reporting. However, this study is the first to analyze augmentation phalloplasty literature in the setting of acquired penile shortening.ConclusionAugmentation phalloplasty techniques for acquired penile shortening are evolving and are continuously being modified; best-practice guidelines are crucial to achieve safe and satisfactory outcomes in this population.
Factors Associated with Midterm Visual Field Variability in Patients with Stable Glaucoma
Guimarães, Maria Emília V. , Dorairaj, Syril , Kanadani, Fábio Nishimura , Gracitelli, Carolina P B , Prata, Tiago S.

Mayo Clinic

Journal of Ophthalmology | December 9, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-7

10.1155/2019/2013160 | PMID 31885882 Get It

Purpose. To evaluate factors associated with midterm visual field (VF) variability in stable glaucoma patients in Brazil.Methods. This retrospective observational study included 59 eyes of 39 stable glaucoma patients. Baseline data assessed were age, gender, educational level, intraocular pressure (IOP), central corneal thickness, best-corrected visual acuity, spherical equivalent, number of hypotensive eye drops, type of glaucoma, number of VFs performed, follow-up in years, lens status, visual field index (VFI) values from the last 5 VF (standard automated perimetry (SAP)) tests, the presence or absence of central scotoma in the VF test, and the level of glaucomatous damage according to the VF mean deviation (MD) index of the last VFs. The 5 latest VFI scores were used to calculate the mean, the standard deviation (SD), and the coefficient of variation (CV). We divided the eyes into 2 groups, being group 1 comprised by the 29 eyes presenting the lowest CV values and group 2 comprised by the 30 eyes presenting the highest CV values. GEE models were used to compare the CV and demographic and clinical parameters of all participants.Results. Mean age of all subjects was 65.8 ± 10.1 years. 54.0% were women. Average SAP MD values for groups 1 and 2 were −2.8 ± 3.1 dB and −6.2 ± 4.1 dB, respectively (P=0.006). Average SAP VFI values for groups 1 and 2 were 95.6 ± 5.9% and 85.9 ± 11.3%, respectively (P=0.002). There was a statistically significant association between CV and SAP MD values (P=0.006). A worse SAP MD and VFI were associated with a higher CV. In addition, even adjusting for potential confounding factors (age and level of education), the association between CV and the SAP MD and between CV and VFI remained significant (P≤0.010).Conclusion. Glaucomatous patients with worse VF sensitivity scores (both MD and VFI indices) present higher VF test variability.
An unusual coronary embolus in a patient with prosthetic endocarditis
Mathew, Jessey , Geske, Jeffrey B. , Luis, Sushil Allen , Geske, Jeffrey B , Schaff, Hartzell V.

Mayo Clinic

European Heart Journal | December 9, 2019 | Volume: 41 | Issue: 23 | Pages: 2179-2179

10.1093/eurheartj/ehz883 | PMID 31848587 Get It

Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents
Szperka, Christina L. , VanderPluym, Juliana H. , Oakley, Christopher, Szperka, Christina L , VanderPluym, Juliana

Mayo Clinic

JAMA Neurology | December 9, 2019 | Volume: 77 | Issue: 3 | Pages: 388

10.1001/jamaneurol.2019.4170 | PMID 31816037 Get It

What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2019? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society
Taner, Timuçin , Martins, Paulo N. , Ng, Kevin TP, Huang, Kuang‐Tzu , Eymard, Corey , Bhat, Mamatha , Bonaccorsi‐Riani, Eliano , Mas, Valeria R. , Selzner, Markus , Ekser, Burcin , Bhat, Mamatha , Ekser, Burcin , Selzner, Markus , Ling, Qi

Mayo Clinic

Transplantation | December 9, 2019 | Volume: 104 | Issue: 3 | Pages: 516-521

10.1097/tp.0000000000003058 | PMID 31815901 Get It

The International Liver Transplantation Society (ILTS) 2019 Annual Congress was held in Toronto, Canada, in May 2019. Members of the ILTS Basic and Translational Research Committee attended all sessions of the meeting and selected the most promising, innovative, and novel research presented. A total of 900 abstracts were presented at the meeting. The percentage of abstracts presented at the ILTS Congress that contains basic or translational research continues to increase, accounting for 15% of all the abstracts in 2019, up from 10% in 2018. Here, we summarize the “what’s hot what’s new” in 5 main themes: liver immunobiology and tolerance, ischemia/reperfusion injury and organ preservation, bioengineering and liver regeneration, hepatic primary tumor biology, and pathophysiology of liver failure.
Nonopioid Modalities for Acute Postoperative Pain in Abdominal Transplant Recipients
Pai, Sher‐Lu , Aniskevich, Stephen , McClain, Robert L., Egan, Brian, Webb, Christopher , McClain, Robert, Pai, Sher-Lu , Aniskevich, Stephen , Chadha, Ryan , Sakai, Tetsuro

Mayo Clinic

Transplantation | December 9, 2019 | Volume: 104 | Issue: 4 | Pages: 694-699

10.1097/tp.0000000000003053 | PMID 31815897 Get It

The field of abdominal organ transplantation is multifaceted, with the clinician balancing recipient comorbidities, risks of the surgical procedure, and the pathophysiology of immunosuppression to ensure optimal outcomes. An underappreciated element throughout this process is acute pain management related to the surgical procedure. As the opioid epidemic continues to grow with increasing numbers of transplant candidates on opioids as well the increase in the development of enhanced recovery after surgery protocols, there is a need for greater focus on optimal postoperative pain control to minimize opioid use and improve outcomes. This review will summarize the physiology of acute pain in transplant recipients, assess the impact of opioid use on post-transplant outcomes, present evidence supporting nonopioid analgesia in transplant surgery, and briefly address the perioperative approach to the pretransplant recipient on opioids.
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Srinagesh, Hrishikesh K. , Özbek, Umut , Kapoor, Urvi , Ayuk, Francis , Aziz, Mina, Ben-David, Kaitlyn , Choe, Hannah , DeFilipp, Zachariah , Etra, Aaron , Hartwell, Matthew J. , Karol, Alexander B. , Kasikis, Stelios, Kitko, Carrie L. , Kowalyk, Steven, Lin, Jung-Yi , Major-Monfried, Hannah , Mielke, Stephan , Morales, George , Ordemann, Rainer, Reddy, Pavan , Reshef, Ran , Rösler, Wolf, Sandhu, Karamjeet , Schechter, Tal , Weber, Daniela , Wölfl, Matthias , Wudhikarn, Kitsada , Young, Rachel , Levine, John E. , Ferrara, James L.M. , Reshef, Ran , Lin, Jung-Yi , Levine, John E , Mielke, Stephan , Grupp, Stephan A. , Hexner, Elizabeth O. , Hogan, William J. , Merli, Pietro , Pulsipher, Michael A. , Qayed, Muna , Shah, Jay, Sigel, Keith Magnus

Mayo Clinic

Blood Advances | December 9, 2019 | Volume: 3 | Issue: 23 | Pages: 4034-4042

10.1182/bloodadvances.2019000791 | PMID 31816061 Get It

Key Points The MAGIC algorithm probability, computed from 2 serum biomarkers, predicts mortality in all GVHD grades after 4 weeks of treatment. Dynamic changes in the MAGIC algorithm probability occur within all biomarker risk groups and can guide therapy.
Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor
Nieborowska-Skorska, Margaret , Paietta, Elisabeth , Levine, Ross L. , Fernández, Hugo F. , Tallman, Martin S. , Litzow, Mark R. , Skórski, Tomasz

Mayo Clinic

Blood Advances | December 9, 2019 | Volume: 3 | Issue: 23 | Pages: 4050-4054

10.1182/bloodadvances.2019000756 | PMID 31816060 Get It

Key Points c-KIT activating mutations cause resistance to PARP inhibitor in AML1-ETO–positive leukemias. c-KIT inhibitor avapritinib downregulates BRCA1/2 and DNA-PK catalytic subunit to restore the sensitivity to PARP inhibitor.
Cash-Based Stem-Cell Clinics
Taliaferro, John , Shapiro, Shane A. , Montero, Daniel , Shi, Glenn G. , Wilke, Benjamin K. , Montero, Daniel P, Shapiro, Shane , Wilke, B K , Shi, Glenn G

Mayo Clinic

JBJS Case Connector | December 9, 2019 | Volume: 9 | Issue: 4 | Pages: e0363-e0363

10.2106/jbjs.cc.19.00363 | PMID 31815806 Get It

Update This article was updated on January 14, 2020, because of a previous error. On page 1, in the Abstract and the section entitled “Case Reports,” the word that had read “Genentech“ now reads “Genetech.” An erratum has been published: JBJS Case Connect. 2020 Feb 5;10(1):e0363ER. Case: The use of biologics is rapidly expanding. Over the past decade, there has been a significant increase in the number of cash-based “stem cell”/regenerative medicine clinics in the United States. These clinics provide cash-based services touting stem cell injections to cure a myriad of conditions. Largely, these clinics are unregulated and using injections in a non–Food and Drug Administration–approved manner. We report on 2 patients who presented with symptoms suggestive of septic arthritis following stem cell injections by cash-based local stem cell clinics. Case 1 involved a patient who developed septic arthritis following an injection of umbilical cord blood–derived cellular products (Genetech) and required an antibiotic spacer followed by a total hip arthroplasty. Case 2 involved a patient who developed a likely immune-mediated reaction following an injection of morselized human placental allograft tissue by a local chiropractic office at a cost of approximately $8,000. Conclusions: We present these cases to bring increased awareness to the issue and call for increased regulation of this practice.
Brain imaging measurements of fibrillar amyloid‐β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele
Ghisays, Valentina , Goradia, Dhruman D., Protas, Hillary , Bauer, Robert, Devadas, Vivek, Tariot, Pierre N. , Lowe, Val J. , Petersen, Ronald C. , Caselli, Richard J. , Reiman, Eric M. , Knopman, David S. , Jack, Clifford R. , Su, Yi , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | December 9, 2019 | Volume: 16 | Issue: 4 | Pages: 598-609

10.1016/j.jalz.2019.08.195 | PMID 31831374 Get It

AbstractIntroductionWe previously characterized associations between brain imaging measurements of amyloid‐β (Aβ) plaque burden and apolipoprotein E (APOE) ε4 gene dose in a small number of cognitively unimpaired late‐middle‐aged APOE ε4 homozygotes (HMs), heterozygotes (HTs), and noncarriers (NCs). We now characterize cross‐sectional Aβ plaque, tau tangle, and cortical atrophy (neurodegeneration) measurements, classifications, and associations with age in a larger number of unimpaired HMs, HTs, and NCs over a wider age range.MethodsWe analyzed 11C Pittsburgh compound B (Aβ) positron emission tomography (PET), flortaucipir (tau) PET, and volumetric magnetic resonance imaging data from 164 study participants of age 47–86 years, including 26 APOE ε4 HMs, 48 HTs, and 90 NCs matched for age and sex.ResultsAβ PET measurements rose, plateaued at the respective ages of 68 and 76, and then declined with age in unimpaired HM and HT groups. Compared with NCs, these two groups began to have significantly higher Aβ PET measurements at ages 62 and 70, respectively, and no longer had significantly higher measurements by ages 71 and 78, respectively. They began to have significantly higher entorhinal cortex tau PET measurements at ages 66 and 70, respectively, and no longer had significantly higher measurements by ages 74 and 78, respectively. Brain atrophy measurements tended to decline slowly with age in all three genetic groups. Their elevated tau PET measurements were attributable to those with positive Aβ PET scans. 41.0%, 18.0%, and 5.0% of the 47‐ to 70‐year‐old HMs, HTs, and NCs and 25.0%, 79.0%, and 38.0% of the 71‐ to 86‐year‐old HMs, HTs, and NCs had positive Aβ PET scans, and the long‐term recall memory scores are significantly higher in the older HMs than in HT and NC groups, suggesting resistance to Aβ deposition in those HMs who remained unimpaired at older ages.ConclusionsThis study provides information about Aβ plaque burden, tau tangle burden, and neurodegeneration in cognitively unimpaired persons at three levels of genetic risk for AD. Unimpaired APOE ε4 HMs can be studied before their 70s to evaluate the understanding of factors, processes, and interventions involved in the predisposition to and prevention of AD, and after their 70s, to discover factors, processes, and interventions involved in the resilience or resistance to and prevention of AD.